calcium sodium fluorophosphosilicate은 임신 중 안전한가요?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments flag reproductive hazard for calcium sodium fluorophosphosilicate; peer‑reviewed literature does not indicate developmental/teratogenic effects from topical cosmetic exposure. The material is an insoluble inorganic glass with low dermal bioavailability under normal topical use, so hazard and mechanism scores remain 0. Sources searched: ECHA Annex VI (no harmonised classification), CIR (no safety restriction), PubMed (no reproductive signals).
Related ingredients
Frequently asked questions
- calcium sodium fluorophosphosilicate은 임신 중 안전한가요?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments flag reproductive hazard for calcium sodium fluorophosphosilicate; peer‑reviewed literature does not indicate developmental/teratogenic effects from topical cosmetic exposure. The material is an insoluble inorganic glass with low dermal bioavailability under normal topical use, so hazard and mechanism scores remain 0. Sources searched: ECHA Annex VI (no harmonised classification), CIR (no safety restriction), PubMed (no reproductive signals).
- calcium sodium fluorophosphosilicate은 모유 수유 중 안전한가요?
- Same rationale as for pregnancy: no regulatory harmonised reproductive classification or published evidence of lactation transfer or milk toxicity from topical use. Low expected dermal/systemic absorption from an insoluble glass limits exposure to breastmilk. Sources: ECHA Annex VI, CIR, PubMed, CosIng/PubChem summary data (no reproductive flags).
- calcium sodium fluorophosphosilicate은 아기 피부에 안전한가요?
- No evidence of reproductive or mechanistic concern in infants. However, neonatal/infant skin barrier is less mature so dermal exposure potential is higher; although the parent material is an insoluble glass with low systemic uptake, per scoring rules exposure for 0–3 yr is increased by +1 relative to adults. No infant‑specific adverse data found in PubMed or regulatory databases. Sources: PubMed, ECHA/CosIng/PubChem summaries (no infant-specific toxicity).
- VeriMom은 calcium sodium fluorophosphosilicate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 calcium sodium fluorophosphosilicate을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 calcium sodium fluorophosphosilicate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.